146 related articles for article (PubMed ID: 11896411)
1. Molecular aspects of hepatic carcinogenesis.
Nita ME; Alves VA; Carrilho FJ; Ono-Nita SK; Mello ES; Gama-Rodrigues JJ
Rev Inst Med Trop Sao Paulo; 2002; 44(1):39-48. PubMed ID: 11896411
[TBL] [Abstract][Full Text] [Related]
2. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
3. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.
Idilman R; De Maria N; Colantoni A; Van Thiel DH
J Viral Hepat; 1998 Sep; 5(5):285-99. PubMed ID: 9795912
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
[TBL] [Abstract][Full Text] [Related]
6. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
7. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
8. Genes and viruses in hepatobiliary neoplasia.
Reeves ME; DeMatteo RP
Semin Surg Oncol; 2000; 19(2):84-93. PubMed ID: 11126384
[TBL] [Abstract][Full Text] [Related]
9. Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.
Tornesello ML; Buonaguro L; Izzo F; Buonaguro FM
Oncotarget; 2016 May; 7(18):25087-102. PubMed ID: 26943571
[TBL] [Abstract][Full Text] [Related]
10. Genetic aspects of hepatocellular carcinogenesis.
Ozturk M
Semin Liver Dis; 1999; 19(3):235-42. PubMed ID: 10518303
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability and p53 mutations in hepatocellular carcinoma.
Karachristos A; Liloglou T; Field JK; Deligiorgi E; Kouskouni E; Spandidos DA
Mol Cell Biol Res Commun; 1999; 2(3):155-61. PubMed ID: 10662591
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of hepatocellular carcinoma type C and B by quantitation of serum HCV-RNA and HBV-DNA using branched DNA probe assay].
Teramoto T; Iwabuchi S; Takatori M; Iino S
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):787-95. PubMed ID: 7563876
[No Abstract] [Full Text] [Related]
17. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.
Kasai Y; Takeda S; Takagi H
Semin Surg Oncol; 1996; 12(3):155-9. PubMed ID: 8727603
[TBL] [Abstract][Full Text] [Related]
19. New insights into hepatitis B and C virus co-infection.
Brass V; Moradpour D
J Hepatol; 2009 Sep; 51(3):423-5. PubMed ID: 19596479
[No Abstract] [Full Text] [Related]
20. Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma.
Yeh SH; Chiu CM; Chen CL; Lu SF; Hsu HC; Chen DS; Chen PJ
Int J Cancer; 2007 Apr; 120(8):1610-7. PubMed ID: 17230529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
